Some are small; others, biological, and there are also medications already approved for another purpose that seek to help in ...

Alzheimer’s disease robs patients of so much more than their health. It can rewire their personalities and undermine a ...

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...

Researchers at Case Western Reserve school of Medicine looked at nearly one million patients in the U.S. with Type 2 diabetes ...

While growing evidence suggests that there’s a link between blood iron levels and the development of Alzheimer’s disease, new ...

Andrew Fein has given his Buy rating due to a combination of factors that highlight the unique positioning of Acumen Pharmaceuticals in the Alzheimer’s treatment landscape. A key differentiator for ...

An 80-something patient came in for an annual visit recently and was worried that recent memory lapses might be symptoms of ...

The drug works by essentially forcing our cells to "spit out" dangerous protein clumps involved in Alzheimer's.

With Eisai and Biogen’s Leqembi and Eli Lilly’s Kisunla launching onto the market, the 2024 Clinical Trials of Alzheimer’s ...

TOKYO (Kyodo) -- A single course of newly approved Alzheimer's drug donanemab-azbt, the second medicine available in Japan ...

An Alzheimer's drug that had been hailed as a major breakthrough may actually increase patients' chance of dying, according to new research. The treatment, lecanemab, was found to triple the risk ...

The findings were presented at the 17th Clinical Trials on Alzheimer's Disease (CTAD) conference. Metabolic and vascular ...